logo
Plus   Neg
Share
Email

Macy's Reiterates FY20 Outlook - Quick Facts

While reporting its financial results for the fourth quarter on Tuesday, Macy's, Inc. (M) reiterated its adjusted earnings and net sales guidance for the full-year 2020.

For fiscal 2020, the company continues to project adjusted earnings in the range of $2.45 to $2.65 per share and adjusted earnings, excluding asset sale gains, in a the range of $2.20 to $2.40 per share.

The company also comparable sales for owned plus licensed to decline 2.5 to 1.5 percent and owned basis to be about 40 basis points better than owned plus licensed.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.45 per share on a revenue decline of 3.0 percent to $23.81 billion for the year. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT